DE60103261D1 - Thiepino[3,2-b]dihydropyridine und relatierte zusammensetzungen und verfahren - Google Patents

Thiepino[3,2-b]dihydropyridine und relatierte zusammensetzungen und verfahren

Info

Publication number
DE60103261D1
DE60103261D1 DE60103261T DE60103261T DE60103261D1 DE 60103261 D1 DE60103261 D1 DE 60103261D1 DE 60103261 T DE60103261 T DE 60103261T DE 60103261 T DE60103261 T DE 60103261T DE 60103261 D1 DE60103261 D1 DE 60103261D1
Authority
DE
Germany
Prior art keywords
thiepino
dihydropyridine
methods
related compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60103261T
Other languages
English (en)
Other versions
DE60103261T2 (de
Inventor
R Henry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of DE60103261D1 publication Critical patent/DE60103261D1/de
Application granted granted Critical
Publication of DE60103261T2 publication Critical patent/DE60103261T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE60103261T 2000-03-23 2001-03-08 Thiepino[3,2-b]dihydropyridine und relatierte zusammensetzungen und verfahren Expired - Fee Related DE60103261T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19165900P 2000-03-23 2000-03-23
US191659P 2000-03-23
PCT/US2001/007416 WO2001070748A1 (en) 2000-03-23 2001-03-08 THIEPINO [3,2-b] DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS

Publications (2)

Publication Number Publication Date
DE60103261D1 true DE60103261D1 (de) 2004-06-17
DE60103261T2 DE60103261T2 (de) 2005-06-02

Family

ID=22706387

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60103261T Expired - Fee Related DE60103261T2 (de) 2000-03-23 2001-03-08 Thiepino[3,2-b]dihydropyridine und relatierte zusammensetzungen und verfahren

Country Status (12)

Country Link
US (1) US6420383B1 (de)
EP (1) EP1265903B1 (de)
JP (1) JP2003528104A (de)
CN (1) CN1247593C (de)
AR (1) AR030198A1 (de)
AT (1) ATE266666T1 (de)
AU (2) AU4732001A (de)
CA (1) CA2403808A1 (de)
DE (1) DE60103261T2 (de)
MX (1) MXPA02009354A (de)
MY (1) MY128266A (de)
WO (1) WO2001070748A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005282028B2 (en) * 2004-09-10 2011-03-24 Newron Pharmaceuticals S.P.A. (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
NZ567540A (en) * 2005-12-22 2010-07-30 Newron Pharm Spa 2-Phenylethylamino derivatives as calcium and/or sodium channel modulators
DK2155663T3 (en) 2007-06-15 2018-01-22 Newron Pharm Spa SUBSTITUTED 2- [2- (PHENYL) ETHYLAMINO] ALKANAMIDE DERIVATIVES AND THEIR USE AS SODIUM AND / OR CALCIUM CHANNEL MODULATORS
HUE030031T2 (en) 2011-06-27 2017-04-28 Newron Pharm Spa Fluorinated arylalkylaminocarboxamide derivatives
WO2013133361A1 (ja) * 2012-03-07 2013-09-12 日立マクセル株式会社 リチウム二次電池パック、並びにそれを用いた電子機器、充電システムおよび充電方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483985A (en) 1978-10-31 1984-11-20 Bayer Aktiengesellschaft Production of 1,4-dihydropyridinecarboxylic acids
US4285955A (en) 1978-10-31 1981-08-25 Bayer Aktiengesellschaft 1,4-Dihydropyridinecarboxylic acids
NZ201395A (en) 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
US4845225A (en) * 1986-04-09 1989-07-04 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno [3,2-b] pyridines
US4705785A (en) * 1986-04-09 1987-11-10 Ortho Pharmaceutical Corporation Substituted thiacycloalkeno (3,2-b) pyridines and pharmaceutical compositions and method of use
US4879384A (en) * 1988-06-15 1989-11-07 Ortho Pharmaceutical Corporation Preparation of thiocycloalkno [3,2-b] pyridines
US5075440A (en) 1990-05-03 1991-12-24 Ortho Pharmaceutical Corporation Novel pyrido[2,3-f](1,4)thiazepines and pyrido[3,2-b](1,5)benzothiazepines
JPH07508030A (ja) * 1992-05-13 1995-09-07 アルコン　ラボラトリーズ，インコーポレイテッド カルシウムアンタゴニストと公知の抗緑内障薬との組合せを含む眼局所用組成物
DE4424678A1 (de) * 1994-07-13 1996-01-18 Bayer Ag Dioxo-thiopyrano-pyridin-carbonsäure-derivate
DE19532320A1 (de) 1995-09-01 1997-03-06 Bayer Ag Verfahren zur Herstellung von optisch aktiven ortho-substituierten 4-Aryl-Dihydropyridinen

Also Published As

Publication number Publication date
CN1522257A (zh) 2004-08-18
AR030198A1 (es) 2003-08-13
CN1247593C (zh) 2006-03-29
AU2001247320B2 (en) 2006-04-27
EP1265903B1 (de) 2004-05-12
US6420383B1 (en) 2002-07-16
MY128266A (en) 2007-01-31
EP1265903A1 (de) 2002-12-18
DE60103261T2 (de) 2005-06-02
MXPA02009354A (es) 2004-05-14
WO2001070748A1 (en) 2001-09-27
JP2003528104A (ja) 2003-09-24
CA2403808A1 (en) 2001-09-27
ATE266666T1 (de) 2004-05-15
AU4732001A (en) 2001-10-03

Similar Documents

Publication Publication Date Title
ATE368018T1 (de) Gipszusammensetzungen und dazugehörende verfahren
ATE452540T1 (de) Zusammensetzung und verfahren
DE69923359D1 (de) Zusammensetzungen und daraus hergestellte gegenstände
DE60229770D1 (de) Reibungsreduzierende zusammensetzung und verfahren
ATA10852001A (de) Bauelement und verfahren zu seiner herstellung
DE60115902D1 (de) Osteoimplantat und verfahren zu seiner herstellung
DE60132732D1 (de) Primerzusammensetzung und Verbindungsverfahren
DE60133303D1 (de) Halbleitergrundmaterial und verfahren zu seiner herstellung
DE50103010D1 (de) Induktives bauelement und verfahren zu seiner herstellung
HUP0301201A3 (en) Methods and compositions utilizing quinazolinones
DE50214717D1 (de) Und verfahren zu seiner herstellung
DE60013027D1 (de) Bauteil und Verfahren zu seiner Herstellung
DE60201475D1 (de) Mit Polyhydroxyalkanoat beschichtetes Liposom und Verfahren zu seiner Herstellung
DE60120830D1 (de) Paketvermittlungssystem und Verfahren
DE60116486D1 (de) Gallengangstent und verfahren zu seiner herstellung
ATE271598T1 (de) Desinfektionszusammensetzungen und verfahren
DE60019627D1 (de) Ferrofluid-zusammensetzung und verfahren
IL154422A0 (en) Paroxetine compositions and processes for making the same
DE60100726D1 (de) Schalterknopf und Verfahren zu dessen Herstellung
DE60010346D1 (de) Als überzüge verwendbare witterungsbeständige zusammensetzungen, verfahren, und damit überzogene artikel
DE69924489D1 (de) Getreide-beta-glukanzusammensetzungen und verfahren
PL352432A1 (en) Neurothrophic pyrolydines and piperidines, their affinite composition and methods of using them
EP1395272A4 (de) Verfahren und zusammensetzungen zur hemmung der durch thrombin induzierten blutgerinnung
DE60122320D1 (de) Rake sythesierungsanordnung und verfahren
DE60103261D1 (de) Thiepino[3,2-b]dihydropyridine und relatierte zusammensetzungen und verfahren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8339 Ceased/non-payment of the annual fee